Bugworks Research Inc., a clinical-stage biopharmaceutical company, is presenting the research findings on its novel, best-in-class, dual-acting adenosine antagonists BWC2094 and BWC2562 with the...

CloserStill Media and the Learning Guild shared program information for their newly expanded Learning & HR Tech Solutions Conference and Expo today. Leaders in learning and HR technology will...

RIYADH, Saudi Arabia, Dec. 7, 2023 /PRNewswire --The prestigious IMA Middle East Annual Conference was successfully hosted in Riyadh on November 4, shining a light on Vision 2030's transformative...

Leading HCM Provider to Host a Premier Three-Day Event Bringing Together Paycor's Customers to Learn, Connect, and Engage CINCINNATI, Dec. 7, 2023 /PRNewswire/ -- Paycor HCM, Inc. ("Paycor")...

Data support the therapeutic potential of REM-422, a first-in-class MYB mRNA degrader Oral dosing of REM-422 in MYB-dysregulated AML PDX models shows robust antileukemic activity WATERTOWN, Mass.,...